about
Tracking the evolution of HIV/AIDS in China from 1989-2009 to inform future prevention and control effortsHIV drug resistance and its impact on antiretroviral therapy in Chinese HIV-infected patientsPredictors of pulmonary tuberculosis treatment outcomes in South Korea: a prospective cohort study, 2005-2012HIV prevalence and risk behaviors among male clients of female sex workers in Yunnan, China.HIV-infected former plasma donors in rural Central China: from infection to survival outcomes, 1985-2008.Cohort profile: the Chinese national free antiretroviral treatment cohortLinezolid for treatment of chronic extensively drug-resistant tuberculosis.Antiretroviral therapy to prevent HIV transmission in serodiscordant couples in China (2003-11): a national observational cohort study.Seroprevalence of antibodies to highly pathogenic avian influenza A (H5N1) virus among close contacts exposed to H5N1 cases, China, 2005-2008.Expanding substance use treatment options for HIV prevention with buprenorphine-naloxone: HIV Prevention Trials Network 058A sterilizing tuberculosis treatment regimen is associated with faster clearance of bacteria in cavitary lesions in marmosetsMortality and treatment outcomes of China's National Pediatric antiretroviral therapy program.The effect of highly active antiretroviral therapy on mortality among HIV-infected former plasma donors in China.Impact of HIV drug resistance on virologic and immunologic failure and mortality in a cohort of patients on antiretroviral therapy in China.Efficacy and safety of metronidazole for pulmonary multidrug-resistant tuberculosisPrevalence and predictors of HIV infection among female sex workers in Kaiyuan City, Yunnan Province, China.Risk factors for human illness with avian influenza A (H5N1) virus infection in China.PET/CT imaging correlates with treatment outcome in patients with multidrug-resistant tuberculosis.PET/CT imaging reveals a therapeutic response to oxazolidinones in macaques and humans with tuberculosis.Distribution of health care expenditures for HIV-infected patients.Effect of earlier initiation of antiretroviral treatment and increased treatment coverage on HIV-related mortality in China: a national observational cohort study.Complete blood cell count as a surrogate CD4 cell marker for HIV monitoring in resource-limited settings.Sustained HIV viral suppression following treatment interruption: an observational study.Using biomarkers to predict TB treatment duration (Predict TB): a prospective, randomized, noninferiority, treatment shortening clinical trialTrends in AIDS-Defining and Non--AIDS-Defining Malignancies among HIV-Infected Patients: 1989-2002Duration of Highly Active Antiretroviral Therapy RegimensImmunologic and Virologic Consequences of Temporary Antiretroviral Treatment Interruption in Clinical Practice
P50
Q28477360-12A903FD-E66B-4192-BEE8-5D2884112719Q28486005-1506CB83-DD36-4F58-A66E-9CC6513D3182Q31170909-380A1FE0-9413-4781-8737-3822F7CCD49BQ33563374-2FF0FB2B-5DD8-4D3F-BFA2-D8AF092AB141Q33742029-4D175169-D3F9-4345-8952-97C88C59E9CAQ34088729-3C92D238-311F-4552-8B77-682DACCFF714Q34644127-061E001D-79F5-4E5C-A891-DC25203FA902Q34645964-57D9209E-0B96-4FDB-9C67-12A0C3A553A2Q34964435-3BCE3A0D-6A14-4C0F-889A-6D34376678C0Q35244943-DAD5E58D-BECD-4C8F-9BE5-77E2C0494D61Q35745991-EB55650F-0594-445A-80D4-304F30801B93Q36853859-19B95708-F0DA-4B1A-BAA4-DC5BFEB20BBFQ36882323-12EF0061-3B96-4F21-B863-86E9C10BD433Q36959418-26E32CDC-DDB6-4ED2-AEE9-EEFA1B9C6DFCQ37036566-B9F81BD9-735B-435C-9243-633762F52A75Q37116199-6F3FC53B-FE52-45AF-9FA7-A07D18936502Q37380324-40CADBFF-64D0-4CB3-9586-EB4473829CD9Q38393463-3A9EE3AB-6036-4049-8E6F-5EE7B0194516Q41619499-6E20CF52-26AB-48CC-9C0F-F410A7FBA9D5Q42699465-A8C11F03-6B30-48BE-B31D-4C396DE0E0B4Q43925184-C784D838-4CEB-4AC7-AB0F-C551044E518BQ46922367-11A5BD75-A36A-4B1E-89F8-0ACEB7C1DC81Q51821870-AEB35099-E338-4997-AA7B-E45BDDA61C29Q57276328-23DCF83F-ECF4-4CE2-A531-2A8D98A53DE6Q58975060-4695C11C-F5F2-437C-AA44-E2438BF2E533Q59307892-A6901FED-98E8-49E1-80BB-AE7C83354BB2Q59307898-7B682DF1-4785-4E95-ABF5-F4D147B270C2
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Ray Y Chen
@es
Ray Y Chen
@nl
Ray Y Chen
@sl
Ray Y. Chen
@en
type
label
Ray Y Chen
@es
Ray Y Chen
@nl
Ray Y Chen
@sl
Ray Y. Chen
@en
prefLabel
Ray Y Chen
@es
Ray Y Chen
@nl
Ray Y Chen
@sl
Ray Y. Chen
@en
P106
P1153
7406314228
P21
P31
P496
0000-0001-6344-1442
P569
2000-01-01T00:00:00Z